Biodegradable MXene Quantum Dots with High Near-Infrared Photothermal Performance for Cancer Treatment

• Published in: ACS applied bio materials 2024-07, Vol.7 (7), p.4339-4351
• Main Authors: Hu, Bingxuan, Chen, Jiawei, Gao, Zeyu, Chen, Lei, Cao, Tengyang, Li, Helang, Yu, Qingsong, Wang, Caiqi, Gan, Zhihua
• Format: Article
• Language: English
• Subjects: Animals; Antineoplastic Agents - chemical synthesis; Antineoplastic Agents - chemistry; Antineoplastic Agents - pharmacology; Biocompatible Materials - chemical synthesis; Biocompatible Materials - chemistry; Biocompatible Materials - pharmacology; Cell Proliferation - drug effects; Cell Survival - drug effects; Drug Screening Assays, Antitumor; Female; Humans; Infrared Rays; Materials Testing; Mice; Mice, Inbred BALB C; Neoplasms, Experimental - drug therapy; Neoplasms, Experimental - pathology; Neoplasms, Experimental - therapy; Particle Size; Photothermal Therapy; Quantum Dots - chemistry; Titanium - chemistry; Titanium - pharmacology
• ISSN: 2576-6422; 2576-6422
• DOI: 10.1021/acsabm.4c00187

Photothermal therapy (PTT) offers significant potential in cancer treatment due to its short, simple, and less harmful nature. However, obtaining a photothermal agent (PTA) with good photothermal performance and biocompatibility remains a challenge. MXenes, which are PTAs, have shown promising results in cancer treatment. This study presents the preparation of Ti3C2 MXene quantum dots (MXene QDs) using a simple hydrothermal and ultrasonic method and their use as a PTA for cancer treatment. Compared to conventional MXene QDs synthesized using only the hydrothermal method, the ultrasonic process increased the degree of oxidation on the surface of the MXene QDs. This resulted in the presence of more hydrophilic groups such as hydroxyl groups on the MXene QD surfaces, leading to excellent dispersion in the aqueous system and biocompatibility of the prepared MXene QDs without the need for surface modification. The MXene QDs showed great photothermal performance with a photothermal conversion efficiency of 62.5%, resulting in the highest photothermal conversion efficiency among similar materials reported thus far. Both in vitro and in vivo experiments have proved the potent tumor inhibitory effect of the MXene QD-mediated PTT, with minimal harm to mice. Therefore, these MXene QDs hold a significant promise for clinical applications.